U.S. flag

An official website of the United States government

NM_006172.4(NPPA):c.272A>G (p.Gln91Arg) AND not specified

Germline classification:
Benign (1 submission)
Last evaluated:
Aug 12, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001194229.1

Allele description [Variation Report for NM_006172.4(NPPA):c.272A>G (p.Gln91Arg)]

NM_006172.4(NPPA):c.272A>G (p.Gln91Arg)

Genes:
NPPA-AS1:NPPA antisense RNA 1 [Gene - HGNC]
LOC114827827:VISTA enhancer hs2123 [Gene]
NPPA:natriuretic peptide A [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.22
Genomic location:
Preferred name:
NM_006172.4(NPPA):c.272A>G (p.Gln91Arg)
HGVS:
  • NC_000001.11:g.11847291T>C
  • NG_012926.1:g.5493A>G
  • NG_065183.1:g.573T>C
  • NM_006172.4:c.272A>GMANE SELECT
  • NP_006163.1:p.Gln91Arg
  • LRG_751t1:c.272A>G
  • LRG_751:g.5493A>G
  • NC_000001.10:g.11907348T>C
  • NM_006172.3:c.272A>G
Protein change:
Q91R
Links:
dbSNP: rs201879717
NCBI 1000 Genomes Browser:
rs201879717
Molecular consequence:
  • NM_006172.4:c.272A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001363592Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Benign
(Aug 12, 2019)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Identification of NPPA variants associated with atrial fibrillation in a Chinese GeneID population.

Ren X, Xu C, Zhan C, Yang Y, Shi L, Wang F, Wang C, Xia Y, Yang B, Wu G, Wang P, Li X, Wang D, Xiong X, Liu J, Liu Y, Liu M, Liu J, Tu X, Wang QK.

Clin Chim Acta. 2010 Apr 2;411(7-8):481-5. doi: 10.1016/j.cca.2009.12.019. Epub 2010 Jan 11.

PubMed [citation]
PMID:
20064500

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV001363592.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant summary: NPPA c.272A>G (p.Gln91Arg) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00017 in 249000 control chromosomes, predominantly at a frequency of 0.0021 within the East Asian subpopulation in the gnomAD database. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 210-folds higher than the estimated maximal expected allele frequency for a pathogenic variant in NPPA causing Arrhythmia phenotype (1e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. c.272A>G has been reported in the literature in individual affected with Arrhythmia, although authors believe the variant to be a polymorphism (Ren_2011). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. A ClinVar submission (evaluation after 2014) cites the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024